• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重症监护病房(ICU)对动脉瘤性蛛网膜下腔出血的管理。

ICU management of aneurysmal subarachnoid hemorrhage.

机构信息

Neurology and Neurosurgery, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA.

出版信息

J Intensive Care Med. 2013 Nov-Dec;28(6):341-54. doi: 10.1177/0885066611434100. Epub 2012 Feb 11.

DOI:10.1177/0885066611434100
PMID:22328599
Abstract

INTRODUCTION

Aneurysmal subarachnoid hemorrhage (SAH) has very high morbidity and mortality rates. Optimal intensive care unit (ICU) management requires knowledge of the potential complications that occur in this patient population.

METHODS

Review of the ICU management of SAH. Level of evidence for specific recommendations is provided.

RESULTS

Grading scales utilizing clinical factors and brain imaging studies can help in determining prognosis and are reviewed. Misdiagnosis of SAH is fairly common so the clinical symptoms and signs of SAH are summarized. The ICU management of SAH is discussed beginning with a focus on avoiding aneurysm re-rupture and securing the aneurysm, followed by a review of the neurologic and medical complications that may occur after the aneurysm is secured. Detailed treatment strategies and areas of current and future research are reviewed.

CONCLUSIONS

The ICU management of the patient with SAH can be particularly challenging and requires an awareness of all potential neurologic and medical complications and their urgent treatments.

摘要

简介

颅内动脉瘤性蛛网膜下腔出血(SAH)的发病率和死亡率都非常高。优化重症监护病房(ICU)管理需要了解此类患者群体中可能出现的潜在并发症。

方法

对 SAH 的 ICU 管理进行综述。对特定建议的证据水平进行了说明。

结果

利用临床因素和脑部影像学研究的分级量表有助于判断预后,并对此进行了综述。SAH 的误诊较为常见,因此总结了 SAH 的临床症状和体征。从避免动脉瘤再破裂和夹闭动脉瘤开始,对 SAH 的 ICU 管理进行了讨论,接着综述了动脉瘤夹闭后可能出现的神经和医学并发症。详细的治疗策略和当前及未来的研究领域也进行了综述。

结论

SAH 患者的 ICU 管理可能特别具有挑战性,需要了解所有潜在的神经和医学并发症及其紧急治疗措施。

相似文献

1
ICU management of aneurysmal subarachnoid hemorrhage.重症监护病房(ICU)对动脉瘤性蛛网膜下腔出血的管理。
J Intensive Care Med. 2013 Nov-Dec;28(6):341-54. doi: 10.1177/0885066611434100. Epub 2012 Feb 11.
2
Aneurysmal subarachnoid hemorrhage: prognostic features and outcomes.动脉瘤性蛛网膜下腔出血:预后特征与结局
New Horiz. 1997 Nov;5(4):364-75.
3
[Subarachnoid haemorrhage--diagnosis and management].[蛛网膜下腔出血——诊断与治疗]
Tidsskr Nor Laegeforen. 2007 Apr 19;127(8):1074-8.
4
Ruptured intracranial aneurysms. A review of diagnosis and management.颅内动脉瘤破裂。诊断与治疗综述。
Minn Med. 2001 May;84(5):26-31.
5
Management of the ruptured aneurysm.破裂动脉瘤的管理。
Neurosurg Clin N Am. 1998 Jul;9(3):525-40.
6
Hypocapnia in aneurysmal subarachnoid hemorrhage: incidence and association with poor clinical outcomes.颅内动脉瘤性蛛网膜下腔出血中的低碳酸血症:发生率及与不良临床结局的关系。
J Neurosurg Anesthesiol. 2013 Jul;25(3):254-61. doi: 10.1097/ANA.0b013e3182806465.
7
Anaesthetic and ICU management of aneurysmal subarachnoid haemorrhage: a survey of European practice.动脉瘤性蛛网膜下腔出血的麻醉与重症监护管理:欧洲实践调查
Eur J Anaesthesiol. 2015 Mar;32(3):168-76. doi: 10.1097/EJA.0000000000000163.
8
[General management in intensive care of patient with spontaneous subarachnoid hemorrhage].[自发性蛛网膜下腔出血患者的重症监护综合管理]
Med Intensiva. 2008 Oct;32(7):342-53. doi: 10.1016/s0210-5691(08)76212-0.
9
[The early diagnosis and therapy of aneurismal subarachnoid hemorrhage].[动脉瘤性蛛网膜下腔出血的早期诊断与治疗]
Zhonghua Wai Ke Za Zhi. 2007 Feb 15;45(4):233-6.
10
Critical care of patients with subarachnoid hemorrhage.蛛网膜下腔出血患者的重症监护
Neurosurg Clin N Am. 1994 Oct;5(4):767-87.

引用本文的文献

1
Contemporary management of aneurysmal subarachnoid haemorrhage. An update for the intensivist.颅内动脉瘤性蛛网膜下腔出血的当代治疗。强化治疗医师的最新进展。
Intensive Care Med. 2024 May;50(5):646-664. doi: 10.1007/s00134-024-07387-7. Epub 2024 Apr 10.
2
Pathophysiology, Management, and Therapeutics in Subarachnoid Hemorrhage and Delayed Cerebral Ischemia: An Overview.蛛网膜下腔出血和迟发性脑缺血的病理生理学、管理与治疗:概述
Pathophysiology. 2023 Sep 14;30(3):420-442. doi: 10.3390/pathophysiology30030032.
3
Clinical risk factors for admission with Pseudomonas and multidrug-resistant Pseudomonas community-acquired pneumonia.
社区获得性肺炎中铜绿假单胞菌和多重耐药铜绿假单胞菌感染的临床危险因素。
Antimicrob Resist Infect Control. 2022 Jul 14;11(1):95. doi: 10.1186/s13756-022-01137-4.
4
Multidrug-resistant organisms (MDROs) in patients with subarachnoid hemorrhage (SAH).颅内出血(SAH)患者的多重耐药菌(MDROs)。
Sci Rep. 2021 Apr 15;11(1):8309. doi: 10.1038/s41598-021-87863-y.
5
Approach to the Diagnosis and Management of Subarachnoid Hemorrhage.蛛网膜下腔出血的诊断与处理方法。
West J Emerg Med. 2019 Mar;20(2):203-211. doi: 10.5811/westjem.2019.1.37352. Epub 2019 Feb 28.
6
Phosphorylation of Akt by SC79 Prevents Iron Accumulation and Ameliorates Early Brain Injury in a Model of Experimental Subarachnoid Hemorrhage.SC79介导的Akt磷酸化可防止铁蓄积并改善实验性蛛网膜下腔出血模型中的早期脑损伤。
Molecules. 2016 Mar 10;21(3):325. doi: 10.3390/molecules21030325.
7
Role of Mitochondrial Calcium Uniporter in Early Brain Injury After Experimental Subarachnoid Hemorrhage.线粒体钙单向转运体在实验性蛛网膜下腔出血后脑早期损伤中的作用
Mol Neurobiol. 2015 Dec;52(3):1637-1647. doi: 10.1007/s12035-014-8942-z. Epub 2014 Nov 5.
8
A Multicenter prospective study of poor-grade aneurysmal subarachnoid hemorrhage (AMPAS): observational registry study.一项关于低级别动脉瘤性蛛网膜下腔出血(AMPAS)的多中心前瞻性研究:观察性登记研究。
BMC Neurol. 2014 Apr 17;14:86. doi: 10.1186/1471-2377-14-86.